Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brooks, C. J.
Right arrow Articles by Savage, C. O. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brooks, C. J.
Right arrow Articles by Savage, C. O. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 5, No. 9, pp. 1041-1048,September 1993
© 1993 Japanese Society for Immunology

Synergistic interactions of CD4+ and CD8+ T cell subsets with human vascular endothelial cells in primary proliferative allogeneic responses

Christopher J. Brooks, Arthur Stackpoole and Caroline O. S. Savage

Vascular Biology Team, Section of Transplantation Biology, Clinical Research Centre Harrow HA1 3UJ, UK

Correspondence to: Correspondence to: C. O. S. Savage

The ability of subcultured human vascular endothelial cells (EC) to provide immune accessory functions for proliferative responses of highly purified allogeneic CD4+ and CD8+ T cells has been examined. CD4+ T cells proliferated in response to IFN-{gamma}-pretreated EC which expressed class II molecules, but not to untreated EC. CD8+ T cells proliferated to MHC class I molecules expressed on both untreated and IFN-{gamma}-treated EC. Combined populations of CD4+ and CD8+ T cells showed synergistic, rather than additive, responses to both untreated and IFN-{gamma}-treated EC. Furthermore, CD8+ T cells were able to induce MHC class II expression on endothelial cells and this induction could be inhibited by an anti-IFN-{gamma} mAb. The synergistic response obtained by co-culturing CD4+ and CD8+ T cells with vascular EC was completely inhibited by the sameantl-IFN-{gamma} mAb. These studies suggest that CD4+ and CD8+ T cells recognise and proliferate to allogeneic MHC molecules expressed by EC. CD4+ and CD8+responses are synergistic under the conditions tested and this synergism appears to be due to induction of MHC class II antigens on C by IFN-{gamma} secreted from CD8+ T cells.

Keywords: endothelial cells, interferon-{gamma}, major histocompatibility complex, peripheral blood lymphocytes

Received 12 January 1993, accepted 17 May 1993.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Xu, K. K. Dhanireddy, and A. D. Kirk
Human Monocytes as Intermediaries between Allogeneic Endothelial Cells and Allospecific T Cells: A Role for Direct Scavenger Receptor-Mediated Endothelial Membrane Uptake in the Initiation of Alloimmunity
J. Immunol., January 15, 2006; 176(2): 750 - 761.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. S. Manavalan, S. Kim-Schulze, L. Scotto, A. J. Naiyer, G. Vlad, P. C. Colombo, C. Marboe, D. Mancini, R. Cortesini, and N. Suciu-Foca
Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity
Int. Immunol., August 1, 2004; 16(8): 1055 - 1068.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Kawai, M. Seki, H. Watanabe, J. W. Eastcott, D. J. Smith, and M. A. Taubman
Th1 transmigration anergy: a new concept of endothelial cell-T cell regulatory interaction
Int. Immunol., June 1, 2000; 12(6): 937 - 948.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.